Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PROX1 | hg38_v1_chr1_+_213989691_213989730 | 0.05 | 7.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_+_21712313 Show fit | 2.69 |
ENST00000390424.2
|
T cell receptor alpha variable 2 |
|
chr14_+_21941122 Show fit | 2.60 |
ENST00000390441.2
|
T cell receptor alpha variable 9-2 |
|
chr12_+_112791933 Show fit | 2.28 |
ENST00000551052.5
ENST00000415485.7 |
rabphilin 3A |
|
chr7_+_142313144 Show fit | 2.22 |
ENST00000390357.3
|
T cell receptor beta variable 4-1 |
|
chr1_-_160862880 Show fit | 2.09 |
ENST00000368034.9
|
CD244 molecule |
|
chr12_+_112791738 Show fit | 1.95 |
ENST00000389385.9
|
rabphilin 3A |
|
chr14_+_22320128 Show fit | 1.94 |
ENST00000390468.1
|
T cell receptor alpha variable 41 |
|
chr1_-_160862700 Show fit | 1.88 |
ENST00000322302.7
ENST00000368033.7 |
CD244 molecule |
|
chr5_+_157142933 Show fit | 1.71 |
ENST00000521769.5
|
IL2 inducible T cell kinase |
|
chr12_+_57583101 Show fit | 1.66 |
ENST00000674858.1
ENST00000675433.1 ENST00000674980.1 |
kinesin family member 5A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 4.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.3 | 4.0 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.0 | 4.0 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 2.4 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 2.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 2.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 2.0 | GO:0007602 | phototransduction(GO:0007602) |
0.4 | 1.7 | GO:0051413 | response to cortisone(GO:0051413) |
0.4 | 1.7 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 2.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 2.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 2.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 2.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 4.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 2.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 2.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 1.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 1.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.5 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.4 | 1.5 | GO:0031208 | POZ domain binding(GO:0031208) |
0.3 | 1.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 2.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 1.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |